Cellular senescence

**Consensus** Cellular senescence(definition) is defined as a state of irreversible growth arrest and altered function that normal somatic cells enter after a finite number of divisions or in response to stressors such as oncogenic *ras* (which induces premature senescence via the accumulation of p53 and p16INK4a) [2, 4, 8]. While replicative senescence and stress-induced arrest function primarily as tumor-suppressive mechanisms to prevent malignant transformation [2, 5], senescent cells accumulate with age and contribute to tissue degeneration [8]. This deleterious impact is largely mediated by the senescence-associated secretory phenotype (SASP), which alters the tissue microenvironment by secreting proinflammatory factors [5].

**Open Questions** Open questions center on the dual, pleiotropic nature of senescence(definition)—specifically, how to selectively target the detrimental, SASP-producing senescent cells that drive tissue dysfunction and "inflamm-aging" without compromising their beneficial tumor-suppressive functions [3, 5]. Additionally, while telomere(definition) shortening has been proposed as the molecular clock triggering replicative senescence [6], the precise regulatory networks governing the transition from acute stress responses to chronic senescence states across diverse cell types remain actively investigated.

**Strength of Evidence** The evidence establishing cellular senescence(definition) as a finite, irreversible growth arrest mechanism tied to tumor suppression is strong, supported by foundational findings on replicative limits, biomarker identification in human skin, and the discovery that oncogenic drivers like *ras* provoke premature arrest through specific tumor suppressor proteins (p53 and p16INK4a) [2, 4]. Evidence is also robust regarding the molecular triggers of replicative limits, such as telomere(definition) shortening, and the subsequent acquisition of the proinflammatory SASP that impacts tissue microenvironments [5, 6].